The invention discloses a
bactrian camel-based anti-goat
pox virus VHH-4-2 and application thereof, and belongs to the field of
biotechnology. The technical scheme includes: screening, expressing, purifying, functional labeling and activity verifying of anti-goat
pox virus VHH-4-2, concentrating and purifying of goat
pox virus, optimizing of various indicators of a kit, etc. The functionally labeled VHH-4-2 is used in the invention, thus avoiding operation steps of primary
antibody, secondary
antibody, anti-
antibody, etc., improving sensitivity and stability, shortening time and saving resources. The
bactrian camel-based anti-goat pox
virus VHH-4-2 breaks through shortcomings that the traditional
Elisa method is time-consuming, laborious, etc. The
bactrian camel-based anti-goat pox
virus VHH-4-2 lays a foundation for establishing a
clinical diagnosis method for sensitive goat pox
virus and for studying the infection mechanism of the virus; and the bactrian camel-based anti-goat pox virus VHH-4-2 also provides a key marker for the development of a goat pox virus antibody-immobilized competitive
Elisa kit with complete proprietary
intellectual property rights. In addition, the attenuated goat pox vaccine is used as a
coating antigen after expanded culture, concentration and purification, so that the sensitivity is improved.